← Back to Search

Contact Lens

Test Lens for Visual Acuity

N/A
Recruiting
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2-weeks of wear
Awards & highlights

Study Summary

This trial will be conducted at multiple locations and will involve both eyes of each participant. It is not randomized, meaning participants will not be assigned to different groups by chance. It is also uncontrolled and

Who is the study for?
This clinical trial is for new contact lens wearers who want to improve their vision. Participants must not have worn contact lenses before and should be interested in trying the Acuvue Oasys 1-Day lenses.Check my eligibility
What is being tested?
The study is testing Acuvue Oasys 1-Day with HydraLuxe Technology, focusing on how well they help people see. It's a single-arm study, meaning everyone gets the same lenses without comparison to another product or placebo.See study design
What are the potential side effects?
Potential side effects may include eye irritation, dryness, discomfort while wearing the lenses, redness of the eyes, and possibly reduced tolerance for long periods of use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2-weeks of wear
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2-weeks of wear for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of eyes with slit-lamp findings (Grade 3 or 4) related to study lens wear

Trial Design

1Treatment groups
Experimental Treatment
Group I: Test LensExperimental Treatment1 Intervention
Eligible subjects will be fitted bilaterally with the TEST lens for approximately 2 weeks of wear (two 1-week wear periods).

Find a Location

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor
217 Previous Clinical Trials
25,676 Total Patients Enrolled
88 Trials studying Visual Acuity
8,891 Patients Enrolled for Visual Acuity
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
45 Previous Clinical Trials
4,550 Total Patients Enrolled
34 Trials studying Visual Acuity
3,920 Patients Enrolled for Visual Acuity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 55 and above eligible to participate in this research study?

"Individuals aged between 13 and 39 are eligible to enroll in this research study based on the specified age requirements."

Answered by AI

Is the enrollment process open for this medical study at present?

"As per the details available on clinicaltrials.gov, this particular research study is not currently in search of participants. This trial was initially posted on March 26th, 2024, and its most recent update was on March 21st, 2024. While this specific trial is inactive for recruitment presently, there are four other ongoing trials that are actively enrolling eligible patients at present."

Answered by AI

At how many different venues is this research endeavor being coordinated?

"Five sites, including Scripps Poway Eyecare & Optometry in San Diego, Omega Vision Center in Longwood, and Kannarr Eye Care in Pittsburg among others are operational for this research study."

Answered by AI
~0 spots leftby May 2024